Search is Powered by Google
Epilepsy News

New Research Reports On Interventions That May Alter The Course Of Epilepsy Diagnosis And Management

Main Category: Epilepsy
Also Included In: Medical Devices / Diagnostics;  Neurology / Neuroscience;  IT / Internet / E-mail
Article Date: 07 Dec 2008 - 4:00 PST

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:5 stars

5 (1 votes)

Health Professional:4 and a half stars

4.5 (2 votes)

Article Opinions: 0 posts

Early diagnosis and treatment that quickly achieves seizure freedom with nominal side effects is the key goal to epilepsy management. Three studies highlighted at the AES annual meeting address this goal from different vantage points: "Each clue we uncover in understanding epilepsy and how to suppress the disruptions it causes for those affected takes us closer to the goal of successfully treating this chronic condition. Data from this year's meeting lead us towards answers about characteristics we can focus on to more effectively diagnose and treat epilepsy," said Dennis D. Spencer, M.D., AES President, Harvey and Kate Cushing Professor and Chair of Neurosurgery, Yale University School of Medicine. "This is especially critical because we know that an estimated one-third of seizures are not controlled with existing therapies."

Epilepsy Patients Achieving Seizure Freedom More Quickly, According to New Analysis

An analysis of epilepsy patients demonstrated that the time to seizure freedom significantly decreased by 10% every year from 1995 to 2005, according to data presented by Jukka Peltola, MD, PhD, Department of Neurology, Tampere University Hospital, Tampere, Finland.

Dr. Peltola and his colleagues studied records of 571 epilepsy patients aged nine to 78 years, who were diagnosed and treated in Tampere University Hospital from 1995 to 2005. Using various methods of analysis, they identified the amount of time for 70% of patients to achieve seizure freedom: "The first-line treatment protocol has not changed over the duration of this study in Finland, but several other changes in the landscape may have contributed to this positive trend. These include new second- and third-line agents, earlier and more aggressive intervention, and greater access to advanced MRI and EEG technology," explained Dr. Peltola. "We are actively analyzing this data further to ascertain the reasons for the decrease in time to seizure freedom. If identified, this could make an important clinical difference."

New EEG Technology - a Seizure Vector Algorithm - Facilitates Seizure Screening in Urgent Care Settings

A group of researchers from Infinite Biomedical Technologies (IBT) and The Johns Hopkins University School of Medicine presented findings demonstrating the accuracy of investigational screening technology designed to assess if a patient's symptoms should be classified as a seizure or another condition.

"Access to an EEG reading, the gold standard for identifying and classifying seizures, is limited in most urgent care settings. Often the EEG machine and/or technologists are not readily available to the Emergency Department (ED), and eventual diagnosis by a specialist may be delayed for hours, or in some cases days," said study author Peter W. Kaplan, MB, FRCP, Professor of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD.

To address this problem, the collaborative team, with grant support from the National Institutes of Health, designed the Seizure Vector (SV) algorithm to express EEG readings as a numeric seizure score. Based on the score, ED staff could quickly classify and triage patients. Potential classifications include: The team's hope is that this technology, when used in the ED setting, will enable first-response personnel to screen for seizures in patients and make rapid triage decisions, such as timely referral to a specialist for evaluation, diagnosis and treatment.

To validate the algorithm, researchers collected EEGs from 40 adults with a variety of seizure types, and a blinded epileptologist classified them into "normal" or "seizure" categories. A total of 2,035 episodes of seizures and 3,867 episodes of normal data were recorded. When the SV algorithm was applied to the same recordings, it differentiated between "seizure" and "normal" episodes with 95.0% sensitivity and 95.2% specificity.

Surveys Reveal Lack of Consensus on Patient Care, Safety Measures in Epilepsy Monitoring Units

A new AES survey of physicians and nurses provided the basis for a working group discussion at this week's meeting regarding a need for the creation of standards in patient care and safety measures in epilepsy monitoring units (EMUs) across the United States.

Patients are admitted to EMUs to determine if they are having seizures, to consider if surgery is an option, for medication changes, or other diagnostic procedures. Some of the monitoring procedures require sleep deprivation and/or taking patients off medications to provoke seizures for simultaneous recording of symptoms and related brain wave activity.

The surveys evaluated EMU practices related to these monitoring procedures, as well as patient supervision. Results revealed discrepancies across EMUs in these areas, with relatively few physicians and nurses reporting that their facilities had protocols in place for seizure monitoring or patient supervision.

"In the continuum of patient care, EMUs are critically important and can significantly drive outcomes," said EMU Study Group member Gregory L. Barkley, MD, Clinical Vice Chair, Department of Neurology, Henry Ford Hospital. "This is why the AES has made it a priority to examine EMUs and formulate best practices and guidelines that will establish a standard, increase efficiency and, most importantly, improve patient outcomes."

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

About the American Epilepsy Society (AES)

AES is a 3,000 member society of physicians and scientists working to improve and advance the treatment of seizures through the promotion of research and education of professionals dedicated to the prevention, treatment and cure of epilepsy.

About Epilepsy

An estimated three million people in the United States have active epilepsy. Among its many causes are genetic factors, head trauma, brain infections, toxins, and complications of birth. Medications are the first line therapy. Brain surgery, electrical stimulation therapy, and, in some children, the ketogenic diet are other forms of therapy that may be used to control or eliminate seizures.

A Multi-Parametric Seizure Screening Algorithm for Clinical EEG
Watson AC, Sherman DL, Kaplan PW, et al.
Abstract # 3.11
Poster presentation on Monday, December 8, 2008 from 8:00 am to 1:30 pm in Convention Center Hall 4B

Decrease in "time to maximum seizure freedom" by year of diagnosis: A new approach to evaluate trend of overall success in epilepsy treatment
Falah M, Kharazmi E, Kolios S, et al.
Abstract # 1.179
Poster presentation on Saturday, December 6 from 1:00 pm to 6:00 pm in Convention Center Hall 4B

Expert Consensus Process on Patient Safety in the Epilepsy Monitoring Unit
Janice M. Buelow, RN, PhD, Chair
Symposium: Saturday, December 6, 2008, 9:00 am - noon, Convention Center Ballroom 6E

In Seattle 12/4-12/9:
American Epilepsy Society Annual Meeting
Press Room: 601, Washington State Convention & Trade Center

Source: Peter Van Haverbeke
American Epilepsy Society




Personalized Homepage Weekly Newsletters Daily News Alerts
Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
What Is Lyrica (pregabalin)? What Does Lyrica Treat?
22 May 2009
Lyrica is Pfizer's trade name for a drug called pregabalin. Pregabalin is an anticonvulsant (anti-seizure) drug that is often used to treat neuropathic pain as well as partial seizures that are common in temporal lobe epilepsy...


Keeping a Personal Medical Record image Keeping a Personal Medical Record

Medical information is usually scattered in many different places. To receive the best possible health care, people are encouraged to gather information in one place and create a personal medical record...

Epilepsy and Sleep image Epilepsy and Sleep

Not all epileptic seizures are noticeable. For some, they can occur while a person is asleep, making epilepsy hard to recognize and also more severe. Learn how to break out of this vicious cycle...

View more videos...